Defective Inflammatory Pathways in Never-Treated Depressed Patients Are Associated with Poor Treatment Response

Neuron
Shariful A SyedCharles B Nemeroff

Abstract

Inflammation has been involved in the pathophysiology and treatment response of major depressive disorder (MDD). Plasma cytokine profiles of 171 treatment-naive MDD patients (none of the MDD patients received an adequate trial of antidepressants or evidence-based psychotherapy) and 64 healthy controls (HCs) were obtained. MDD patients exhibited elevated concentrations of 18 anti- and proinflammatory markers and decreased concentrations of 6 cytokines. Increased inflammasome protein expression was observed in MDD patients, indicative of an activated inflammatory response. The plasma of MDD patients was immunosuppressive on healthy donor peripheral blood mononuclear cells, inducing reduced activation of monocytes/dendritic cells and B cells and reduced T cell memory. Comparison between 33 non-responders and 71 responders at baseline and 12 weeks revealed that after treatment, anti-inflammatory cytokine levels increase in both groups, whereas 5 proinflammatory cytokine levels were stabilized in responders, but continued to increase in non-responders. MDD patients exhibit remodeling of their inflammatory landscape.

Citations

Jan 12, 2019·British Journal of Pharmacology·Francis J HermanGiulio M Pasinetti
May 18, 2019·Expert Review of Neurotherapeutics·Mbemba Jabbi, Charles B Nemeroff
Jun 20, 2019·Psychiatry and Clinical Neurosciences·Tomoyuki Furuyashiki, Shiho Kitaoka
Jul 8, 2020·International Journal of Molecular Sciences·Xavier O ScottJuan Pablo de Rivero Vaccari
Aug 24, 2020·Journal of Neuroinflammation·Ryan J WorthenEleonore Beurel
Sep 4, 2020·Journal of Neuroinflammation·Vaidya GovindarajanRobert W Keane
Jan 1, 2019·PloS One·Nadine KerrJuan Pablo de Rivero Vaccari
Feb 15, 2019·International Journal of Molecular Sciences·Zhiwen ZhouRyuta Koyama
Sep 10, 2020·Frontiers in Pharmacology·Mahtab ForouzandehJuan Pablo de Rivero Vaccari
Feb 6, 2019·Frontiers in Neurology·Anelia A Y KassiShyam Gajavelli
Nov 19, 2020·International Journal of Molecular Sciences·Brianna CyrJuan Pablo de Rivero Vaccari
Feb 1, 2020·Biological Psychiatry·Mary-Ellen LynallUNKNOWN Neuroimmunology of Mood Disorders and Alzheimer’s Disease (NIMA) Consortium
Jun 20, 2020·Neuron·Eléonore BeurelCharles B Nemeroff
Mar 24, 2021·Journal of Affective Disorders·Nunzio PomaraKaj Blennow
Apr 2, 2021·The American Journal of Psychiatry·Charles B Nemeroff
May 30, 2021·Psychoneuroendocrinology·Wansu QiuLiisa A M Galea
Jun 4, 2021·Translational Neuroscience·Nan ZhangZhongchun Liu
Jul 7, 2021·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Dae Jong OhKi Woong Kim
Sep 10, 2021·Neurocritical Care·Jon Pérez-BárcenaJuan Pablo de Rivero Vaccari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Brain developing: Influences & Outcomes

This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.